This HTML5 document contains 55 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/domain/vavai/projekt/
n10http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n15http://linked.opendata.cz/ontology/domain/vavai/
n7http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F68378050%3A_____%2F03%3A23033052%21RIV%2F2004%2FGA0%2FA23004%2FN/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n4http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F68378050%3A_____%2F03%3A23033052%21RIV%2F2004%2FGA0%2FA23004%2FN
rdf:type
n15:Vysledek skos:Concept
dcterms:description
Moderately immunogenic HPV16-associated tumours, MHC class I+ and class I-, were used to examine the adjuvant effects of IL-2 and dendritic cells for surgical therapy. It has been found that in both types of tumours recombinant IL-2 and IL-2 gene-modified vaccines substantially reduced the tumour recurrence rate and inhibited tumour growth. The dendritic cells were effective only in surgical therapy of MHC class I+ tumours. Moderately immunogenic HPV16-associated tumours, MHC class I+ and class I-, were used to examine the adjuvant effects of IL-2 and dendritic cells for surgical therapy. It has been found that in both types of tumours recombinant IL-2 and IL-2 gene-modified vaccines substantially reduced the tumour recurrence rate and inhibited tumour growth. The dendritic cells were effective only in surgical therapy of MHC class I+ tumours.
dcterms:title
Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16. Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.
skos:prefLabel
Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16. Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.
skos:notation
RIV/68378050:_____/03:23033052!RIV/2004/GA0/A23004/N
n3:strany
891;896
n3:aktivita
n16:Z n16:P
n3:aktivity
P(GA301/00/0114), P(GA301/01/0985), P(IAA5052203), P(IAA7052002), P(NC7148), Z(AV0Z5052915)
n3:cisloPeriodika
9-10
n3:dodaniDat
n4:2004
n3:domaciTvurceVysledku
n10:9414185 n10:3714977 n10:8003726 n10:1572830 n10:6215319
n3:druhVysledku
n17:J
n3:duvernostUdaju
n13:S
n3:entitaPredkladatele
n12:predkladatel
n3:idSjednocenehoVysledku
610923
n3:idVysledku
RIV/68378050:_____/03:23033052
n3:jazykVysledku
n6:eng
n3:klicovaSlova
interleukin-2; HPV 16; dendritic cells
n3:klicoveSlovo
n5:dendritic%20cells n5:HPV%2016 n5:interleukin-2
n3:kodStatuVydavatele
NL - Nizozemsko
n3:kontrolniKodProRIV
[CEB2F3EBA5DC]
n3:nazevZdroje
Vaccine
n3:obor
n18:FD
n3:pocetDomacichTvurcuVysledku
5
n3:pocetTvurcuVysledku
7
n3:pocetUcastnikuAkce
0
n3:pocetZahranicnichUcastnikuAkce
0
n3:projekt
n14:GA301%2F00%2F0114 n14:GA301%2F01%2F0985 n14:NC7148 n14:IAA7052002 n14:IAA5052203
n3:rokUplatneniVysledku
n4:2003
n3:svazekPeriodika
21
n3:tvurceVysledku
Šmahel, M. Vonka, V. Mikyšková, Romana Indrová, Marie Bubeník, Jan Šímová, Jana Mendoza, Luis
n3:zamer
n7:AV0Z5052915
s:issn
0264-410X
s:numberOfPages
6